Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence

Although sphingosine 1-phosphate (S1P) has been reported to play an important role in cancer pathophysiology, little is known about S1P and hepatocellular carcinoma (HCC). To clarify the relationship between S1P and HCC, 77 patients with HCC who underwent surgical treatment were consecutively enrolled in this study. In addition, S1P and its metabolites were quantitated by LC-MS/MS. The mRNA levels of sphingosine kinases (SKs), which phosphorylate sphingosine to generate S1P, were increased in HCC tissues compared with adjacent non-HCC tissues. Higher mRNA levels of SKs in HCC were associated with poorer differentiation and microvascular invasion, whereas a higher level of SK2 mRNA was a risk factor for intra- and extra-hepatic recurrence. S1P levels, however, were unexpectedly reduced in HCC compared with non-HCC tissues, and increased mRNA levels of S1P lyase (SPL), which degrades S1P, were observed in HCC compared with non-HCC tissues. Higher SPL mRNA levels in HCC were associated with poorer differentiation. Finally, in HCC cell lines, inhibition of the expression of SKs or SPL by siRNA led to reduced proliferation, invasion and migration, whereas overexpression of SKs or SPL enhanced proliferation. In conclusion, increased SK and SPL mRNA expression along with reduced S1P levels were more commonly observed in HCC tissues compared with adjacent non-HCC tissues and were associated with poor differentiation and early recurrence. SPL as well as SKs may be therapeutic targets for HCC treatment.

[1]  J. Aoki,et al.  Separation and quantification of 2-acyl-1-lysophospholipids and 1-acyl-2-lysophospholipids in biological samples by LC-MS/MS , 2014, Journal of Lipid Research.

[2]  T. Wakai,et al.  Sphingosine-1-Phosphate Transporters as Targets for Cancer Therapy , 2014, BioMed research international.

[3]  J. Saba,et al.  S1pping fire: Sphingosine-1-phosphate signaling as an emerging target in inflammatory bowel disease and colitis-associated cancer , 2014, Clinical and experimental gastroenterology.

[4]  A. Kihara.  Sphingosine 1-phosphate is a key metabolite linking sphingolipids to glycerophospholipids. , 2014, Biochimica et biophysica acta.

[5]  Y. Inoue,et al.  High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potential , 2014, International journal of cancer.

[6]  A. Don,et al.  Re-Configuration of Sphingolipid Metabolism by Oncogenic Transformation , 2014, Biomolecules.

[7]  K. McDonald,et al.  A Metabolic Shift Favoring Sphingosine 1-Phosphate at the Expense of Ceramide Controls Glioblastoma Angiogenesis* , 2013, The Journal of Biological Chemistry.

[8]  K. Xie,et al.  Altered Sphingolipid Metabolism in Patients with Metastatic Pancreatic Cancer , 2013, Biomolecules.

[9]  K. Rex,et al.  Sphingosine Kinase Activity Is Not Required for Tumor Cell Viability , 2013, PloS one.

[10]  Eugene Y. Kim,et al.  Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. , 2013, Cancer cell.

[11]  Y. Inoue,et al.  Antagonism of sphingosine 1‐phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct‐ligated rodents , 2012, Hepatology.

[12]  O. Cuvillier,et al.  First Evidence of Sphingosine 1-Phosphate Lyase Protein Expression and Activity Downregulation in Human Neoplasm: Implication for Resistance to Therapeutics in Prostate Cancer , 2012, Molecular Cancer Therapeutics.

[13]  T. Kasten,et al.  Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1. , 2012, The Biochemical journal.

[14]  Xianghuo He,et al.  Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[15]  Thomas P Mathews,et al.  Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate. , 2011, The Biochemical journal.

[16]  Liying Li,et al.  Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility. , 2011, Journal of hepatology.

[17]  Charles D Smith,et al.  Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts , 2011, Cancer biology & therapy.

[18]  S. Pyne,et al.  Sphingosine 1-phosphate and cancer , 2010, Nature Reviews Cancer.

[19]  S. Yue,et al.  Involvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasis-induced liver fibrosis. , 2009, The American journal of pathology.

[20]  Hong Wang,et al.  Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. , 2009, Journal of hepatology.

[21]  Tonya S. King,et al.  Sphingosine kinase 1 protein and mRNA are overexpressed in non-Hodgkin lymphomas and are attractive targets for novel pharmacological interventions , 2008, Leukemia & lymphoma.

[22]  J. Chun,et al.  The sphingosine 1‐phosphate receptor S1P2 triggers hepatic wound healing , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  J. Cyster,et al.  Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate , 2007, Science.

[24]  D. Herr,et al.  Sphingosine 1-Phosphate (S1P) Signaling Is Required for Maintenance of Hair Cells Mainly via Activation of S1P2 , 2007, The Journal of Neuroscience.

[25]  A. Borowsky,et al.  Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer , 2006, Proceedings of the National Academy of Sciences.

[26]  A. Dubin,et al.  Emerging medicinal roles for lysophospholipid signaling. , 2006, Trends in molecular medicine.

[27]  Thomas W Prior,et al.  Sphingosine Kinase-1 Expression Correlates With Poor Survival of Patients With Glioblastoma Multiforme: Roles of Sphingosine Kinase Isoforms in Growth of Glioblastoma Cell Lines , 2005, Journal of neuropathology and experimental neurology.

[28]  A. Kihara,et al.  Products by the sphingosine kinase/sphingosine 1‐phosphate (S1P) lyase pathway but not S1P stimulate mitogenesis , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[29]  F. X. Bosch,et al.  Epidemiology of hepatocellular carcinoma. , 2005, Clinics in liver disease.

[30]  S. Chae,et al.  Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. , 2004, The Journal of clinical investigation.

[31]  Amy P N Skubitz,et al.  Differential gene expression in ovarian carcinoma: identification of potential biomarkers. , 2004, The American journal of pathology.

[32]  Y. Inoue,et al.  Sphingosine 1-phosphate enhances portal pressure in isolated perfused liver via S1P2 with Rho activation. , 2004, Biochemical and biophysical research communications.

[33]  J. Chun,et al.  Lysophospholipid receptors: signaling and biology. , 2004, Annual review of biochemistry.

[34]  Brian D. Lee,et al.  Discovery and evaluation of inhibitors of human sphingosine kinase. , 2003, Cancer research.

[35]  Y. Inoue,et al.  Antiproliferative property of sphingosine 1-phosphate in rat hepatocytes involves activation of Rho via Edg-5. , 2003, Gastroenterology.

[36]  J. Chun,et al.  In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice. , 2002, Biochimica et biophysica acta.

[37]  Tomio Sasaki,et al.  Sphingosine 1-Phosphate Contracts Canine Basilar Arteries In Vitro and In Vivo: Possible Role in Pathogenesis of Cerebral Vasospasm , 2001, Stroke.

[38]  J. P. Hobson,et al.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. , 2000, The Journal of clinical investigation.

[39]  H. Ikeda,et al.  Biological activities of novel lipid mediator sphingosine 1-phosphate in rat hepatic stellate cells. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[40]  S. Spiegel,et al.  Involvement of Sphingosine 1-Phosphate in Nerve Growth Factor-Mediated Neuronal Survival and Differentiation , 1997, The Journal of Neuroscience.

[41]  S. Spiegel,et al.  Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate , 1996, Nature.

[42]  S. Hakomori,et al.  Quantitative measurement of sphingosine 1-phosphate in biological samples by acylation with radioactive acetic anhydride. , 1995, Analytical biochemistry.

[43]  S. Spiegel,et al.  Involvement of a Pertussis Toxin-sensitive G Protein in the Mitogenic Signaling Pathways of Sphingosine 1-Phosphate (*) , 1995, The Journal of Biological Chemistry.

[44]  S. Spiegel,et al.  Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens , 1993, Nature.